Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome

被引：0
|
作者：
Zik, Chad [1 ]
Alan, Sheinei [1 ]
Ershler, William B. [1 ]
机构：
[1] Inova Schar Canc Inst, Adult Sickle Cell Ctr, Fairfax, VA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170745
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11157 / 11158
页数：2
相关论文
共 50 条
  • [31] Recognizing Moyamoya Disease in a Soldier With Recurrent Cerebrovascular Symptoms
    Jeong, Paul S.
    MILITARY MEDICINE, 2023, 188 (7-8) : E2769 - E2771
  • [32] The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
    Delgado, Julio
    Voltz, Caroline
    Stain, Milena
    Lapvetelainen, Tuomo
    Urach, Susanne
    Lahteenvuo, Johanna
    Penttila, Karri
    Gisselbrecht, Christian
    Enzmann, Harald
    Pignatti, Francesco
    HEMASPHERE, 2021, 5 (07): : E604
  • [33] Moyamoya syndrome associated with sickle cell trait in a child
    Komur, Mustafa
    Unal, Selma
    Okuyaz, Cetin
    Ozgur, Anil
    BRAIN & DEVELOPMENT, 2014, 36 (06): : 545 - 547
  • [34] Crizanlizumab-Associated Painful Febrile Reaction in Sickle Cell Disease Patients
    Li, Valery J.
    Adesina, Oyebimpe O.
    Fertrin, Kleber Yotsumoto
    BLOOD, 2021, 138
  • [35] Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease
    Miller, ST
    Rao, SP
    BLOOD, 2003, 102 (04) : 1556 - 1556
  • [36] Complete Neurologic Recovery of Cerebral Fat Embolism Syndrome in Sickle Cell Disease
    Oyedeji, Oluwayomi
    Anusim, Nwabundo
    Alkhoujah, Mohammad
    Dabak, Vrushali
    Otrock, Zaher K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [37] Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency
    Saxena, Parima
    Alkaissi, Hussam
    Chauhan, Riddhi
    Muthu, John
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [38] Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome
    Asma, Suheyl
    Boga, Can
    Tan, Meliha
    Kasar, Mutlu
    Yeral, Mahmut
    Ulusan, Serife Nur
    EUROPEAN JOURNAL OF THERAPEUTICS, 2013, 19 (03): : 205 - 206
  • [39] GENERAL-CASE OF THE DAY - MOYAMOYA SYNDROME IN A CHILD WITH SICKLE-CELL DISEASE
    DREW, JM
    SCOTT, JA
    CHUA, GT
    RADIOGRAPHICS, 1993, 13 (02) : 483 - 484
  • [40] Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease
    Sherwin K. B. Sy
    Chiaki Tanaka
    Kai Grosch
    Clinical Pharmacokinetics, 2023, 62 : 249 - 266
12345